Adcirca 20 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F74GE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,921
Award facts
- Contract value 100% obligated
- $11,921.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 22, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides 60 tablets of Adcirca 20 mg with a ceiling value of $11,921.29 and a firm fixed-price structure. The contract carries no set-aside designation and is scheduled for ultimate completion by January 23, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement supply chain, primarily serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent company, Cencora, Inc., holds the underlying IDC with DLA and has demonstrated extensive capability in fulfilling diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for federal military and veteran healthcare programs. The delivery of Adcirca, a prescription medication used in the treatment of pulmonary hypertension, exemplifies the company's role in supplying specialty pharmaceuticals to support federal health system operations.
Quick answers
Who was awarded contract SPE2DR26F74GE?
SPE2DR26F74GE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F74GE worth?
The government has obligated $11,921 on SPE2DR26F74GE.
Is contract SPE2DR26F74GE an order under another contract?
Yes. SPE2DR26F74GE is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74GE competed?
The extent of competition for SPE2DR26F74GE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award